期刊文献+

粒细胞缺乏期以腹部症状为首发感染表现的临床分析

Clinical analysis of abdominal symptoms as the first manifestations of infection in agranulocytosis
下载PDF
导出
摘要 目的探讨化疗后粒细胞缺乏期以腹部症状为首发感染表现的临床特点。方法回顾性分析烟台毓璜顶医院2010年1月至2021年3月期间化疗后粒细胞缺乏期以腹部症状为首发感染表现的35例恶性血液病患者,男20例,女15例,中位年龄42岁。观察并记录其临床特征、实验室检查及影像学检查结果的特点。结果35例患者化疗后粒细胞缺乏期间,起初均无发热,但均有不同程度并发腹部症状,表现为不明原因腹痛、腹胀、咽痛、吞咽不适、恶心、呕吐、返酸、呃逆、腹泻等症状,查体发现腹部无固定部位压痛、肠鸣音亢进、腹肌紧张等体征。其中30例粒细胞缺乏患者出现上述症状及体征后才有发热,且热峰时间较长,均大于2 h,实验室检查结果提示C反应蛋白(CRP)、降钙素原均明显升高,1,3-β-D葡聚糖检测(G试验)、半乳甘露聚糖检测(GM试验)无异常,4例粪培养阳性,6例血培养阳性,21例腹部CT为脂膜炎性改变、肠腔胀气、肠管积气及肠管增厚等表现。结论粒细胞缺乏期,感染致死率较高,但不是所有患者均以发热为首发表现,要警惕以腹部症状为首发表现的感染,这群患者表现比较特殊,且腹部症状无特异性表现,极易漏诊,延误诊治,临床需提高警惕;在粒细胞缺乏期一旦出现不明显原因的腹部症状,要及时完善实验室、影像学检查,密切监测体温,及时抗感染治疗,降低患者病死率。 Objective To investigate the clinical characteristics of abdominal symptoms as the first manifestations of infection in agranulocytosis after chemotherapy.Methods This was a retrospective observational study on 35 patients with hematologic malignancy with abdominal symptoms as the first manifestations of infection in agranulocytosis after chemotherapy in Yantai Yuhuangding Hospital from January 2010 to March 2021,including 20 males and 15 females,with a median age of 42 years old.The clinical features,laboratory examination and imaging results were observed and recorded.Results During the stage of agranulocytosis after chemotherapy,none of the 35 patients had fever at the beginning,but all of them had abdominal symptoms to varying degrees,including unexplained abdominal pain,abdominal distension,sore throat,swallowing discomfort,nausea,vomiting,sour regurgitation,hiccups,diarrhea,and other symptoms.Physical examination showed that there were no fixed abdominal tenderness,bowel sounds,and abdominal muscle tension.Among them,30 patients with agranulocytosis had fever only after the above symptoms and signs,and the heat peak time was longer than 2 hours.Laboratory examination results showed that C-reaction protein(CRP)and procalcitonin significantly increased,and G test and GM test were normal.Fecal culture was positive in 4 cases,and blood culture was positive in 6 cases.Abdominal CT showed panniculitis,flatulence,pneumatosis,and intestinal thickening in 21 cases.Conclusions In the agranulocytosis stage,the mortality rate from infection is high,but not all patients present with fever as their first manifestation.Those with abdominal symptoms as the first manifestations of infection need to be paid attention to,this group of patients is special,has no specific manifestations of abdominal symptoms,which is easy to miss diagnosis and delay diagnosis and treatment,and requires clinical vigilance.In the agranulocytosis stage,once there are abdominal symptoms of no obvious causes,timely laboratory and imaging examinations,close monitoring of body temperature,and timely anti-infection treatment should be performed to reduce the mortality rate of patients.
作者 李晓飞 王静 Li Xiaofei;Wang Jing(Clinical Medical College of Binzhou Medical College,Binzhou 264003,China;ICU,Yantai Yuhuangding Hospital,Yantai 264000,China)
出处 《国际医药卫生导报》 2021年第20期3209-3212,共4页 International Medicine and Health Guidance News
关键词 粒细胞缺乏期 腹部症状 感染 Agranulocytosis Abdominal symptoms Infection
  • 相关文献

参考文献1

二级参考文献10

  • 1NCCN clinical practice guidelines in oncology TM. Prevention and treatment of cancer-related infections (v. 2. 2009).
  • 2Crump M, Gluck S, Tu D,et al. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA. 16[J]. J Clin Oncol, 2008, 26(1):37-43.
  • 3Biron P, Durand M, Roche H, et ah Pegase 03: a prospective randomized phase Ⅲ trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer[J].Bone Marrow Transplant, 2008, 41(6):555-562.
  • 4Lotz J P, Cure H, Janvier M, et al. High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol [J]. Eur J Cancer, 2005,41(1):71-80.
  • 5Genser S, Salepsi T, Ozer S. Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients[J]. J Infect, 2003,47(1) :65-72.
  • 6Hughes W T, Armstrong D, Bodey G P, et al. 2002 guidelines for the use of antimicrohial agents in neutropenie patients with cancer[J]. Clin Infect Dis, 2002,34(6) : 730-751.
  • 7Curry M P, Afdhal N H. Use of growth factors with antiviral therapy for chronic hepatitis C[J]. Clin Liver Dis, 2005,9(3):439 -451.
  • 8Kuderer N M, Dale D C, Crawford J, et al. Mortality, morbidity, and eostassociated with febrile neutropenia in adult cancer patients[J]. Cancer, 2006, 106(10):2258-2266.
  • 9汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2008年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2009,9(5):321-329. 被引量:422
  • 10医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320. 被引量:5840

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部